GBM-specific investigations have shown valproic acid treatment in vitro causes increased p21 WAF1/Cip1 expression in multiple cell lines and sensitization to TMZ treatment in GBM cell lines but not in primary GSC cultures derived from human tumors (70, 71). Here, CDKN1A is linked to glioblastoma.